Gain insights on investment strategies, partnerships, fundraising, and market dynamics to support innovation and long-term growth.
Investing in Women’s Health Products and Companies
September 24, 2026
1:00 PM – 2:00 PM
Investing in Women’s Health Products and Companies
September 24, 2026
1:00 PM – 2:00 PM
AdvaMed’s 2026 Women’s Health Webinar Series unites the medtech industry to explore opportunities in women’s health innovation. The second webinar in this free series, developed in partnership with the Medtech Investment Working Group, will closely examine the investment ecosystem for women’s health products and companies, focusing on both successes and challenges.
With 30 years of strategic experience across corporations, start-ups, and investment firms, our moderator will lead a discussion with experienced leaders shaping the future of women’s health investment. Throughout the conversation, participants will gain valuable insights into investment strategies, partnerships, and market trends influencing the development of new technologies. In addition, the webinar welcomes women’s health start-ups, diverse investors (e.g., VCs, private equity), and industry leaders interested in advancing innovation.
Whether you are leading a women’s health start-up or investing in emerging technologies, this webinar offers valuable perspectives. Join AdvaMed to gain actionable insights and connect with the voices shaping the future of women’s health.
Who Should Attend
This webinar is designed for:
- Women’s health start-ups and early-stage company leaders
- Founders, CEOs, and executive leaders
- Venture capital and private equity investors
- Corporate venture and strategic investment teams
- Business development and innovation leaders
- Entrepreneurs and innovators developing women’s health technologies
- Medtech professionals interested in women’s health market trends
Speakers
Moderator: Terri Burke, Senior Partner, Intuitive Ventures

Terri leads Intuitive Ventures’ investment strategy & platform by guiding investments that transform care. She scales impact across global medtech and digital health markets, collaborating with portfolio companies to support innovations that address significant unmet clinical needs and next horizon challenges in healthcare. Terri has cultivated 30 years of strategic expertise working across corporations, start-ups and investment firms, including Epidarex Capital’s Fund III US/UK, Protaryx Medical, Edwards Lifesciences, Guidant Corporation and Covance Health Economics & Outcomes Services.
She is a Trustee for the Roessler-Chadwick Foundation, an early member of MedtechWOMEN and has served on multiple startup boards. She holds a BS in Biology from Duke University and an MBA from the University of Southern California.
Amy Degenkolb, CEO, Founder, Novocuff

Amy Degenkolb is an engineer, co-founder, and CEO of Novocuff, where she leads the company’s efforts to improve outcomes in maternal health. Since 2012, she has focused her career on developing medical technologies for women, motivated by the need to address an area of medicine that has historically received limited investment and attention. As a lead engineer on the JADA System for postpartum hemorrhage, she contributed to a technology addressing one of the leading causes of maternal mortality. That experience reinforced her commitment to advancing meaningful innovation in women’s and maternal health.
Lisa Suennen, Managing Partner, American Heart Association Ventures

Lisa Suennen has spent over 35 years as venture capitalist, entrepreneur, operating executive, strategy consultant and board director. She has worked extensively across tech-enabled services, digital health, medical devices, and diagnostics.
Lisa is Managing Partner of American Heart Association Ventures, a platform of venture funds focused on cardiovascular and brain health, including Go Red for Women, Cardeation Capital, the Social Impact Fund and Studio Red.
Lisa previously held multiple venture fund leadership roles (Psilos Group, GE Ventures, Manatt Ventures) and executive roles at Canary Medical, Manatt, Phelps & Phillips, and Merit Behavioral Care, where she was instrumental in driving company growth from startup through IPO and acquisition. Lisa was founding CEO of CSweetener, which mentors rising female healthcare leaders (sold to HLTH Foundation).
Lisa chairs Australia’s ANDHealth’s International Investment Committee and serves on the advisory boards of Nina Capital and PROOF VC. She is a National Advisor for Manatt Health and a Fellow of the Aspen Institute’s Health Innovators Fellowship and is on faculty at the UC Berkeley Haas School of Business.
Lisa was featured in Forbes 2025 List of the 50 Over 50, writes the Venture Valkyrie blog, and is an internationally recognized author and speaker.
Additional speakers to be announced soon.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.